In the evolving world of healthcare and medical technology, leadership today demands more than clinical expertise—it requires vision, adaptability, and the ability to translate science into meaningful impact. Few leaders represent this modern approach as powerfully as Dr. Anna J. Schreiner, Chief Medical Officer at MedTec Medizintechnik GmbH in Giessen, Germany, and MBST® Global.
A board-certified Orthopedic Surgeon, academic contributor, and global medical leader, Dr. Anna has built a career at the intersection of patient care, research, and innovation. Her journey reflects a commitment to advancing medicine beyond traditional boundaries—bringing clinical insight directly into the development of therapies that shape the future of musculoskeletal care.
A Foundation Built in Clinical Excellence
Dr. Anna’s professional journey began in the operating room. Trained in orthopedics and trauma surgery, she worked in leading orthopedic centers where precision, responsibility, and patient trust defined daily practice. These years provided not only technical expertise, but also a deep understanding of the real challenges faced by patients with musculoskeletal conditions—challenges that often extend far beyond surgical intervention.
Driven by scientific curiosity and a strong commitment to evidence-based medicine, Dr. Anna expanded her clinical path through a research fellowship in the United States. This experience broadened her international perspective and strengthened her interest in innovation-driven healthcare models.
Alongside her clinical work, she remained deeply engaged in academia. She continues to hold teaching roles, including appointments at Eberhard Karls University of Tübingen, contributing to medical education and mentoring the next generation of physicians. Teaching and research, for Dr. Anna, are not parallel pursuits—they are integral to shaping responsible and forward-thinking medicine.
Recognizing the Need for a New Vision of Medicine
As her clinical experience deepened, Dr. Anna began to identify a recurring pattern. Many of the challenges encountered in orthopedic practice—treatment effectiveness, recovery time, long-term joint health—could not be fully addressed through surgery or pharmacology alone.
This realization became a turning point.
Dr. Anna envisioned a future of medicine that places greater emphasis on physical therapies, personalized treatment strategies, and intelligent combination therapies—approaches that support healing while minimizing invasiveness.
Rather than viewing this insight as a limitation of clinical practice, she saw it as an opportunity to expand her impact. Transitioning into medical technology leadership allowed her to bridge frontline care with therapy innovation, shaping solutions that respond directly to the needs of healthcare professionals and patients alike.
From Surgeon to Medical Technology Leader
Dr. Anna’s appointment as Chief Medical Officer at MBST® Global and MedTec Medizintechnik GmbH marked a defining chapter in her career. In this role, she brings together clinical expertise, scientific rigor, and strategic leadership—ensuring that innovation remains grounded in medical reality.
For Dr. Anna, medical technology must serve a clear purpose: to improve outcomes, support clinicians, and integrate seamlessly into real-world healthcare environments.
She maintains close and continuous exchange with healthcare professionals across Germany and international markets, listening to their experiences, understanding their challenges, and identifying unmet clinical needs. This dialogue forms the foundation of MBST®’s innovation strategy.
Under her medical leadership, feedback from clinicians is systematically integrated into research and development, clinical evaluations, and education programs. New clinical studies, collaborations with universities and research institutions, and active academic engagement ensure that MBST® therapies remain evidence-based, relevant, and aligned with evolving standards of care.
Navigating Complexity in a Transforming Industry
The orthopedic medical device industry is undergoing rapid transformation. Increasing regulatory requirements, the demand for robust clinical evidence, and the need for global adaptability present complex challenges.
Dr. Anna views these dynamics as an opportunity to raise the bar.
Advances in imaging, regenerative medicine, and data-driven treatment optimization are reshaping how musculoskeletal conditions are diagnosed and managed. Technologies that enhance recovery, personalize care, and promote long-term joint health are becoming central to modern orthopaedics.
Within this landscape, Dr. Anna positions MBST® as part of a broader, integrated treatment philosophy—one that emphasizes non-invasive, evidence-based physical therapies as essential components of comprehensive care pathways.
Expanding MBST® on a Global Stage
One of the milestones Dr. Anna is particularly proud of is the international expansion of MBST® therapy.
This growth was driven by more than market strategy. It was built through close collaboration with healthcare professionals worldwide, enabling MBST® to be adapted to diverse clinical needs and healthcare systems.
In parallel, Dr. Anna has been instrumental in strengthening scientific awareness of Magnetic Resonance Therapy (MRT, MBST®). Through scientific publications, expert articles, webinars, and educational initiatives, she has helped translate complex research into practical clinical knowledge.
Strategic collaborations—with universities, research institutions, industry partners, and AI experts—have further accelerated innovation. These partnerships support the continuous evolution of MBST® technology while generating new clinical insights that inform future therapy development.
A strong presence at national and international conferences has reinforced MBST®’s visibility and credibility—positioning it not only as a technology, but as part of a new vision of modern medicine.
Leadership Rooted in Purpose
For Dr. Anna, leadership in healthcare and medtech is defined by responsibility, empathy, and integrity.
She believes that effective leadership requires understanding the realities faced by both patients and healthcare providers, embracing interdisciplinary collaboration, and having the courage to innovate responsibly within complex systems.
To young medical professionals aspiring to leadership roles, Dr. Anna emphasizes the importance of clinical excellence paired with curiosity about the broader healthcare ecosystem. Mentorship, openness to new environments, and a strong ethical compass are essential qualities for navigating the future of medicine.
Above all, she encourages emerging leaders to remain connected to their original motivation.
Medicine, she believes, must always be guided by purpose—the commitment to make a meaningful difference in people’s lives.
Shaping the Future of Orthopaedic Care
As healthcare systems worldwide seek solutions that are effective, sustainable, and patient-centred, leaders like Dr. Anna J. Schreiner are shaping the way forward.
By bridging orthopaedics, academia, and medical technology leadership, Dr. Anna is helping redefine how musculoskeletal conditions are treated—championing innovation, evidence, and non-invasive therapies as cornerstones of modern care.
For Business Fame Magazine, her story is one of vision, adaptability, and impact—a powerful example of how purposeful leadership can transform both medicine and industry.
